Article Information
History
- December 30, 2022.
Article Versions
- Version 1 (March 11, 2022 - 05:48).
- Version 2 (November 17, 2022 - 08:36).
- Version 3 (December 16, 2022 - 06:31).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- 1Department of Neurology, University of California, San Francisco & the San Francisco VA Medical Center, San Francisco, CA, USA
- 2Center for Neuro-engineering and Therapeutics, University of Pennsylvania, Philadelphia, PA, USA
- 3Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France
- ↵*Address for Correspondence: Douglas S. Goodin, MD, Department of Neurology, University of California, San Francisco, UCSF MS Center, 675 Nelson Rising Lane, Suite #221D, San Francisco, CA 94158, Phone: (415) 514 2464, Fax: (415) 514 2470, E mail: douglas.goodin{at}ucsf.edu
Author Contributions DSG: Conceptualized and led the project, wrote the analytic software, analyzed and interpreted the data, and wrote the original draft of the manuscript.
PK: Assisted in data interpretation and review of the manuscript.
PA: Assisted in data interpretation and review of the manuscript.
NV: Assisted in data interpretation, and review of the manuscript.
Posted December 30, 2022.
Multiple Sclerosis: Exploring the Limits of Genetic and Environmental Susceptibility
